HIV Drug Resistance - PAHO/WHO | Pan American Health …
Sep 21, 2023 · HIV drug resistance (HIVDR) is the ability of HIV to mutate and reproduce in the presence of antiretroviral (ARV) drugs. The consequences of drug resistance include treatment failure; the transmission of drug resistant HIV; as well as increased direct and indirect costs, for patients and health systems, due to more expensive, complex and toxic second- and third-line …
HIV/AIDS - PAHO/WHO | Pan American Health Organization
Sep 30, 2024 · ART reduces mortality and morbidity rates among HIV-infected people, and improves their quality of life. The benefits of ART also include the prevention of HIV transmission by suppressing HIV replication in persons living with the virus. This benefit of ART is also defined as “undetectable equal untransmittable” , or U=U.
New HIV infections, deaths and persons living with HIV receiving ART in Latin America and the Caribbean ...
Guidelines for managing advanced HIV disease and rapid ... - PAHO
Jul 7, 2017 · Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
Updated recommendations on first-line and second-line ... - PAHO
Dec 21, 2018 · This web page provides interim guidance on first- and second-line antiretroviral regimens, post-exposure prophylaxis and early infant diagnosis of HIV. It updates the 2016 WHO guidelines with new evidence and experience on dolutegravir, raltegravir and virological testing.
Pre-Exposure Prophylaxis (PrEP) - PAHO/WHO | Pan American …
Dec 5, 2023 · PrEP is a HIV medication that reduces the risk of infection by over 90% for people at substantial risk. WHO guidelines recommend daily PrEP use and provide a tool for implementing PrEP programs in various settings and populations.
HIV/AIDS: 40 years tackling an epidemic that has marked humanity
The web page traces the history and response of PAHO/WHO to the HIV/AIDS epidemic in Latin America and the Caribbean since 1981. It highlights the achievements, challenges and milestones in prevention, treatment and advocacy, but does not answer the query directly.
Consolidated guidelines on the use of antiretroviral drugs for …
Jun 21, 2016 · These guidelines cover the diagnosis, prevention, treatment and care of HIV infection with antiretroviral (ARV) drugs. They do not mention the acidic environment for ARV drugs absorption or adherence.
More developing countries show universal access to HIV/AIDS
Sep 28, 2010 · Global treatment coverage for HIV positive children was 28% in 2009, a notable progress, but the rate is lower than the ART coverage for adults (36%). And only 15% of children born to HIV-positive mothers were receiving appropriate infant diagnostics. "Every day, more than 1 000 infants acquire HIV during pregnancy, delivery and breastfeeding.
Consolidated guidelines on HIV prevention, testing, treatment
Jul 16, 2021 · Overview These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and programmatic recommendations across different ages, populations and settings, bringing together all relevant WHO guidance on HIV produced since 2016. It serves as an update to the previous edition of …